博雅生物：截至目前，公司共计拥有2张血液制品生产牌照、21个单采血浆站

Group 1 - The core inquiry from investors is whether China Resources Group possesses blood station resources and if it will inject these into Boya Bio [2] - Boya Bio (300294.SZ) confirmed on the investor interaction platform that it is part of the China Resources Health sector's blood products platform [2] - As of now, Boya Bio holds a total of 2 blood product production licenses and operates 21 single plasma collection stations, including 4 under the Green Cross brand [2]